mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMC 208450)

Published in J Bacteriol on January 01, 1990

Authors

I del Castillo1, J M Gómez, F Moreno

Author Affiliations

1: Unidad de Genética Molecular, Hospital Ramón y Cajal, Madrid, Spain.

Articles citing this

Functions of the gene products of Escherichia coli. Microbiol Rev (1993) 15.51

Proton-dependent multidrug efflux systems. Microbiol Rev (1996) 8.81

Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A (1992) 5.30

Stationary-phase-inducible "gearbox" promoters: differential effects of katF mutations and role of sigma 70. J Bacteriol (1991) 4.30

Linkage map of Escherichia coli K-12, edition 10: the traditional map. Microbiol Mol Biol Rev (1998) 4.18

EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol (1995) 2.99

The MarR repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli: prototypic member of a family of bacterial regulatory proteins involved in sensing phenolic compounds. Mol Med (1995) 1.93

Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance. Antimicrob Agents Chemother (1996) 1.48

Nucleotide sequence of the Escherichia coli regulatory gene mprA and construction and characterization of mprA-deficient mutants. J Bacteriol (1991) 1.30

Characterization of a chimeric proU operon in a subtilin-producing mutant of Bacillus subtilis 168. J Bacteriol (1995) 1.20

The gene slyA of Salmonella typhimurium is required for destruction of M cells and intracellular survival but not for invasion or colonization of the murine small intestine. Infect Immun (1996) 1.14

Characterization of Borrelia burgdorferi BlyA and BlyB proteins: a prophage-encoded holin-like system. J Bacteriol (2000) 1.05

Use of phoA and lacZ fusions to study the membrane topology of ProW, a component of the osmoregulated ProU transport system of Escherichia coli. J Bacteriol (1996) 1.00

Growth-phase-dependent expression of the cyclopeptide antibiotic microcin J25. J Bacteriol (2001) 0.96

Predicting transcriptional regulatory interactions with artificial neural networks applied to E. coli multidrug resistance efflux pumps. BMC Microbiol (2008) 0.84

Identification and characterization of EctR1, a new transcriptional regulator of the ectoine biosynthesis genes in the halotolerant methanotroph Methylomicrobium alcaliphilum 20Z. J Bacteriol (2009) 0.84

Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli. J Bacteriol (2016) 0.77

Articles cited by this

Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65

Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87

Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38

The physical map of the whole E. coli chromosome: application of a new strategy for rapid analysis and sorting of a large genomic library. Cell (1987) 46.35

Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol (1976) 33.01

Linkage map of Escherichia coli K-12, edition 7. Microbiol Rev (1983) 30.35

Simple method for identification of plasmid-coded proteins. J Bacteriol (1979) 20.53

Plasmid insertion mutagenesis and lac gene fusion with mini-mu bacteriophage transposons. J Bacteriol (1984) 12.63

Nucleotide sequence of an insertion element, IS1. Proc Natl Acad Sci U S A (1978) 11.43

Physiological and genetic responses of bacteria to osmotic stress. Microbiol Rev (1989) 10.77

A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell (1988) 6.80

Versatile low-copy-number plasmid vectors for cloning in Escherichia coli. Gene (1982) 6.62

Mutations that alter the signal sequence of alkaline phosphatase in Escherichia coli. J Bacteriol (1983) 6.27

The use of transposon TnphoA to detect genes for cell envelope proteins subject to a common regulatory stimulus. Analysis of osmotically regulated genes in Escherichia coli. J Mol Biol (1987) 4.98

An E. coli promoter induced by the cessation of growth. Mol Microbiol (1987) 3.26

The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J (1988) 3.25

A new family of low molecular weight antibiotics from enterobacteria. Biochem Biophys Res Commun (1976) 3.08

Binding protein dependent transport of glycine betaine and its osmotic regulation in Escherichia coli K12. Mol Gen Genet (1986) 2.72

Characterization of a cloned Bacillus subtilis gene that inhibits sporulation in multiple copies. J Bacteriol (1986) 2.59

DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression. J Bacteriol (1988) 2.54

Nucleotide sequence of the osmoregulatory proU operon of Escherichia coli. J Bacteriol (1989) 2.26

Identification, cloning, and expression of bolA, an ftsZ-dependent morphogene of Escherichia coli. J Bacteriol (1988) 2.22

Growth phase and ompR regulation of transcription of microcin B17 genes. J Bacteriol (1986) 2.15

DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J Bacteriol (1989) 2.07

Isolation, characterization, and nucleotide sequence of appY, a regulatory gene for growth-phase-dependent gene expression in Escherichia coli. J Bacteriol (1989) 1.97

Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol (1985) 1.90

Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol (1986) 1.89

Pleiotropic mutations in appR reduce pH 2.5 acid phosphatase expression and restore succinate utilisation in CRP-deficient strains of Escherichia coli. Mol Gen Genet (1986) 1.82

The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins (1986) 1.80

Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J Gen Microbiol (1986) 1.79

Plasmid genes required for microcin B17 production. J Bacteriol (1985) 1.59

appR gene product activates transcription of microcin C7 plasmid genes. J Bacteriol (1989) 1.56

Cloning and mapping of the genetic determinants for microcin C7 production and immunity. J Bacteriol (1986) 1.53

Structure and mode of action of microcin 7, an antibacterial peptide produced by Escherichia coli. Antimicrob Agents Chemother (1985) 1.38

Cloned structural genes for the osmotically regulated binding-protein-dependent glycine betaine transport system (ProU) of Escherichia coli K-12. Mol Microbiol (1988) 1.36

Molecular cloning of an osmoregulatory locus in Escherichia coli: increased proU gene dosage results in enhanced osmotolerance. J Bacteriol (1986) 1.26

Microcin 7: purification and properties. Biochem Biophys Res Commun (1984) 1.21

Osmoregulation in Escherichia coli: complementation analysis and gene-protein relationships in the proU locus. J Bacteriol (1989) 1.19

Alp, a suppressor of lon protease mutants in Escherichia coli. J Bacteriol (1989) 1.14

Identification of the gene appA for the acid phosphatase (pH optimum 2.5) of Escherichia coli. Mol Gen Genet (1985) 1.08

Effects of microcin B17 on microcin B17-immune cells. J Gen Microbiol (1986) 0.90

Articles by these authors

Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31

An E. coli promoter induced by the cessation of growth. Mol Microbiol (1987) 3.26

The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J (1988) 3.25

Genetic analysis of bacteriophage phi 29 of Bacillus subtilis: integration and mapping of reference mutants of two collections. J Virol (1976) 2.38

Genetics of ribosomally synthesized peptide antibiotics. Annu Rev Microbiol (1992) 2.35

Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31

Bacillus subtilis phage phi29. Characterization of gene products and functions. Eur J Biochem (1976) 2.17

Growth phase and ompR regulation of transcription of microcin B17 genes. J Bacteriol (1986) 2.15

A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11

DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J Bacteriol (1989) 2.07

The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J (1991) 2.04

Suppressor-sensitive mutants and genetic map of Bacillus subtilis bacteriophage phi 29. Virology (1974) 2.01

A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00

Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol (1985) 1.90

Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol (1986) 1.89

Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet (1996) 1.83

The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins (1986) 1.80

Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J Gen Microbiol (1986) 1.79

Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals. J Clin Endocrinol Metab (2012) 1.78

Chemical structure and translation inhibition studies of the antibiotic microcin C7. J Biol Chem (1995) 1.73

Gene ompR and regulation of microcin 17 and colicin e2 syntheses. J Bacteriol (1982) 1.70

Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus. Nat Genet (2001) 1.68

Lens injuries induced by occupational exposure in non-optimized interventional radiology laboratories. Br J Radiol (1998) 1.66

The transposon Tn5 carries a bleomycin-resistance determinant. Gene (1984) 1.65

The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli. Eur J Biochem (1999) 1.64

Plasmid genes required for microcin B17 production. J Bacteriol (1985) 1.59

Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25. J Bacteriol (1999) 1.57

An unusual mechanism for resistance to the antibiotic coumermycin A1. Proc Natl Acad Sci U S A (1991) 1.57

Transposition of the great arteries with posterior aorta, anterior pulmonary artery, subpulmonary conus and fibrous continuity between aortic and atrioventricular valves. Am J Cardiol (1971) 1.57

appR gene product activates transcription of microcin C7 plasmid genes. J Bacteriol (1989) 1.56

A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet (2004) 1.56

The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology (2003) 1.54

Cloning and mapping of the genetic determinants for microcin C7 production and immunity. J Bacteriol (1986) 1.53

Structure and organization of plasmid genes required to produce the translation inhibitor microcin C7. J Bacteriol (1995) 1.51

The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol Microbiol (1997) 1.45

The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae. Biochem J (2001) 1.44

Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes. Yeast (1995) 1.42

Selective immediate allergic response to penicillin V. Allergy (1996) 1.41

dacD, an Escherichia coli gene encoding a novel penicillin-binding protein (PBP6b) with DD-carboxypeptidase activity. J Bacteriol (1996) 1.40

Depth of a strong jovian jet from a planetary-scale disturbance driven by storms. Nature (2008) 1.40

Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest (2007) 1.39

Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum Mol Genet (1995) 1.39

Magnetic and electric coherence in forward- and back-scattered electromagnetic waves by a single dielectric subwavelength sphere. Nat Commun (2012) 1.39

The smallest known gene. Nature (1994) 1.38

Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol (1990) 1.37

Genetic analysis of microcin H47 antibiotic system. J Bacteriol (1993) 1.34

Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss. J Med Genet (2002) 1.34

Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31

Nucleotide sequence of the Escherichia coli regulatory gene mprA and construction and characterization of mprA-deficient mutants. J Bacteriol (1991) 1.30

A suppressor of nonsense mutations in Bacillus subtilis. Eur J Biochem (1974) 1.30

The centromere and promoter factor, 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4. Mol Gen Genet (1993) 1.29

Evidence of linkage disequilibrium in the Spanish polycystic kidney disease I population. Am J Hum Genet (1994) 1.28

The ICL1 gene from Saccharomyces cerevisiae. Eur J Biochem (1992) 1.28

Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27

Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet (2003) 1.23

The A1555G mutation in the 12S rRNA gene of human mtDNA: recurrent origins and founder events in families affected by sensorineural deafness. Am J Hum Genet (1999) 1.23

Mitral atresia with normal aortic valve: a study of eighteen cases and a review of the literature. Circulation (1976) 1.18

Hexokinase PII has a double cytosolic-nuclear localisation in Saccharomyces cerevisiae. FEBS Lett (1998) 1.18

The hexokinase 2 protein participates in regulatory DNA-protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae. FEBS Lett (1998) 1.16

Tpk3 and Snf1 protein kinases regulate Rgt1 association with Saccharomyces cerevisiae HXK2 promoter. Nucleic Acids Res (2006) 1.16

Hydrodynamic Maxwell demon in granular systems. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.15

Mutations in the aphA-2 gene of transposon Tn5 mapping within the regions highly conserved in aminoglycoside-phosphotransferases strongly reduce aminoglycoside resistance. Mol Microbiol (1991) 1.08

sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17. Mol Microbiol (1995) 1.08

Mutation profile of the MYO7A gene in Spanish patients with Usher syndrome type I. Hum Mutat (2006) 1.07

DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains. Sex Transm Dis (1995) 1.05

MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet (2007) 1.05

Rates of synthesis of polyadenylated messenger RNA and ribosomal RNA during the cell cycle of Schizosaccharomyces pombe. With an appendix: calculation of the pattern of protein accumulation from observed changes in the rate of messenger RNA synthesis. J Cell Sci (1976) 1.04

OmpC and LamB proteins can serve as substitute receptors for host range mutants of coliphage TuIa. J Bacteriol (1980) 1.04

Evidence that colicin X is microcin B17. J Bacteriol (1987) 1.04

Molecular forms of yeast invertase. Eur J Biochem (1975) 1.03

A cysteine substitution in the zona pellucida domain of alpha-tectorin results in autosomal dominant, postlingual, progressive, mid frequency hearing loss in a Spanish family. J Med Genet (2001) 1.03

Hemangiomas of the head, neck, and chest with associated vascular and brain anomalies: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol (1996) 1.02

Functional characterization of transcriptional regulatory elements in the upstream region of the yeast GLK1 gene. Biochem J (1999) 1.01

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol (2013) 1.01

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat (1995) 0.99

Development of a molecular diagnostic test applied to experimental abattoir surveillance on bovine tuberculosis. Vet Microbiol (2007) 0.99

Patient dose reference levels for interventional radiology: a national approach. Cardiovasc Intervent Radiol (2008) 0.98

Invertase and alpha-galactosidase synthesis by yeast. Cell Mol Biol Incl Cyto Enzymol (1979) 0.98

A novel locus for non-syndromic sensorineural deafness (DFN6) maps to chromosome Xp22. Hum Mol Genet (1996) 0.97

Microcin-E492-insensitive mutants of Escherichia coli K12. J Gen Microbiol (1986) 0.97

Microcin B17, a novel tool for preparation of maxicells: identification of polypeptides encoded by the IncFII minireplicon pMccB17. J Bacteriol (1988) 0.97

Catabolite inactivation of isocitrate lyase from Saccharomyces cerevisiae. Arch Microbiol (1987) 0.96

Refining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2. Am J Hum Genet (1995) 0.96

Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci (1999) 0.96

The hexokinase isoenzyme PII of Saccharomyces cerevisiae ia a protein kinase. J Gen Microbiol (1989) 0.96

A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA50, maps to chromosome 7q32 between the DFNB17 and DFNB13 deafness loci. J Med Genet (2004) 0.96

Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Cytokine (2006) 0.96

Toxic effects of dissolved heavy metals on Desulfovibrio vulgaris and Desulfovibrio sp. strains. J Hazard Mater (2006) 0.96

Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity. FEMS Microbiol Lett (2001) 0.95

Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C->T mutation in the mitochondrial 12S rRNA gene. J Med Genet (2006) 0.95

Comparative study of open abdomen treatment: ABThera™ vs. abdominal dressing™. Hernia (2014) 0.95

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. J Am Coll Cardiol (1992) 0.95

A new colorimetric assay for UDP-glucose 4-epimerase activity. Cell Mol Biol Incl Cyto Enzymol (1981) 0.94

Identification and characterisation of two transcriptional repressor elements within the coding sequence of the Saccharomyces cerevisiae HXK2 gene. Nucleic Acids Res (1996) 0.94

Transcriptional regulation of the isocitrate lyase encoding gene in Saccharomyces cerevisiae. FEBS Lett (1993) 0.94

Directionality in scattering by nanoparticles: Kerker's null-scattering conditions revisited. Opt Lett (2011) 0.93

Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf) (2007) 0.92

Reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation of incessant supraventricular tachycardia in infants. Br Heart J (1995) 0.92